title: Antipsychotic-associated all-cause and cardiac mortality: what should we worry about and how should the risk be assessed?
authors.forename: Christoph U
authors.initials: CU
authors.lastname: Correll
authors.forename: Jimmi
authors.initials: J
authors.lastname: Nielsen
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003627:Data Interpretation, Statistical; D006331:Heart Diseases / Q000139:chemically induced / Q000401:mortality*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D012307:Risk Factors; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy / Q000401:mortality
chemical_list: D014150:Antipsychotic Agents; D007093:Imidazoles; D007211:Indoles; C066304:sertindole; D018967:Risperidone